The Global Market for Deep Brain Stimulation (DBS) Devices is Projected to Reach US$901 Million by 2020

Unmet Medical Needs in Neurological Disorders to Drive Demand for Deep Brain Stimulation Devices, According to a New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on the Deep Brain Stimulation Devices. The global market for Deep Brain Stimulation (DBS) Devices is projected to reach US$901 million by 2020, driven by the high prevalence of neurological & psychiatric disorders, unmet medical needs, and use of DBS devices in new approved indications.

Rising prevalence of neurological and psychiatric disorders is driving demand for novel therapies and treatment. While pharmacological therapy remains the first-line treatment for these conditions, their limited effectiveness has prompted the development of alternative therapeutic options. Deep Brain Stimulation is one such therapy that is attracting significant interest among researchers, clinicians and patients alike, largely due to the established efficacy of the treatment, and a slew of conditions the therapy is indicated for and the potential it holds to gain approval for several others. DBS is a neurosurgical technique that involves electrical stimulation of select areas of the brain using an implanted system, to achieve symptom reduction of diseases. DBS devices comprise an implantable pulse generator, a lead extension and electrodes. Over the years, DBS showed remarkable therapeutic benefits in various otherwise treatment-resistant conditions in both research studies and clinical practice.

Deep Brain Stimulation has revolutionized the treatment paradigm of certain neurological diseases, such as Parkinson’s disease, Essential Tremor and Dystonia, offering optimism and hope to several patients in pursuit of better quality of life. Aging population, unmet medical needs in the area of neurology, development of novel devices, increase in treatment indications, robust R&D investments and technology developments, are key factors driving growth in the market. Also, advances in functional neuroanatomy, neuroimaging, neurophysiology and neuromodulation are paving way for new therapeutic possibilities for DBS. Banking on the success of DBS procedures in the treatment of Parkinson’s disease and essential tremor, researchers are investigating the efficacy of the procedure in treating a range of other disorders. Conditions ranging from depression, addiction disorders, eating disorders, Alzheimer’s, and even obesity have found space in this ambit.

Technological advances are enabling performance and efficacy improvements of DBS devices. Over the recent years, the market witnessed the emergence of new pulse generators, replacing conventional products with limited functionality and agility. Novel features such as interleaving stimulation or multiprogramming became a possibility with these devices. More recent advances include the shift towards closed loop functionality, which generates stimulation based on activation from sensors thereby addressing the negative outcomes of continuous stimulation typical of traditional DBS systems. Closed loop stimulation has shown in studies to be more effective than the conventional open-loop based systems. Another advancement that is presently under investigation is multidirectional DBS leads.

As stated by the new market research report on Deep Brain Stimulation Devices, the United States represents the largest market, worldwide. High incidence and prevalence of neurological conditions, growing awareness over available therapies, sophisticated and well-established healthcare infrastructure and significant expertise and experience among surgeons in DBS are the major factors spurring the dominance of the country in the global market. Asia-Pacific ranks as the fastest growing market with a CAGR of 13.7% over the analysis period.

Major players covered in the report include Aleva Neurotherapeutics SA, Boston Scientific Corp., Deep Brain Innovations, LLC, Medtronic, plc, and St. Jude Medical, Inc.

The research report titled “Deep Brain Stimulation Devices: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, acquisitions and other strategic industry activities of major companies worldwide. The report provides market estimates and projections in US$ for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil and Rest of Latin America) and Rest of World.